Biofil Chemicals & Pharmaceuticals Ltd. (BIOFILCHEM) Price & Analysis

Compare

0 Followers

BIOFILCHEM Stock Chart & Stats

₹33.59

-₹0.32(-0.55%)

At close: Jan 09 4:00 PM EST

₹33.59

-₹0.32(-0.55%)

Day’s Range― - ―

52-Week Range₹28.79 - ₹56.36

Previous CloseN/A

Volume25.08K

Average Volume (3M)6.87K

Market Cap

₹494.72M

Enterprise Value₹494.21M

Total Cash (Recent Filing)₹2.55M

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)17.8

Beta1.51

Next Earnings

Jun 03, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.05

Shares Outstanding16,273,800

10 Day Avg. Volume7,559

30 Day Avg. Volume6,869

Financial Highlights & Ratios

PEG Ratio-5.50

Price to Book (P/B)3.72

Price to Sales (P/S)2.09

P/FCF Ratio-34.48

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Balance Sheet StrengthA manageable debt-to-equity ratio and healthy balance sheet provide durable financial flexibility. This allows the company to withstand cyclical downturns, access debt markets on reasonable terms, and fund selective investments or working capital without over-reliance on dilutive financing, supporting stability over the medium term.

Margin Sustainability / Operational EfficiencyStable gross margins and persistent positive EBIT/EBITDA margins despite revenue headwinds point to structural operational efficiency. This margin resilience helps preserve profitability when top line softens, supports reinvestment capacity, and provides a buffer that sustains long-term cash generation potential even in slower demand periods.

Strong Equity Ratio / Capital StructureA strong equity ratio and positive ROE indicate shareholder capital underpins operations, lowering solvency risk and improving lender confidence. This capital base enables the company to pursue necessary capex or strategic initiatives without excessively increasing leverage, preserving optionality and funding stability across cycles.

Bears Say

Revenue DeclineA material year-over-year revenue decline undermines scale economics and may reflect demand loss or intensifying competition. Sustained top-line contraction pressures fixed-cost absorption, reduces future EBITDA expansion potential, and forces management to reallocate resources or pursue strategic shifts to restore durable growth.

Weak Cash Generation / Negative FCFInconsistent operating cash flow and negative free cash flow driven by elevated capex constrain internal funding for operations, dividends, or M&A. Persistent negative FCF increases liquidity and refinancing risk, limits financial flexibility for strategic investments, and raises reliance on external financing in the medium term.

Profitability VolatilityVolatile net profit margins and earnings create uncertainty for long-term profitability and forecasting. Earnings swings impair capital-allocation decisions, reduce investor confidence in sustainable returns, and make it harder to plan consistent dividends or growth investments, elevating execution risk over the coming quarters.

Biofil Chemicals & Pharmaceuticals Ltd. News

Biofil Chemicals Announces Virtual AGM and E-Voting

An update from Biofil Chemicals & Pharmaceuticals Ltd. ( ($IN:BIOFILCHEM) ) is now available. Biofil Chemicals & Pharmaceuticals...

6M ago

Biofil Chemicals Appoints New Company Secretary

The latest announcement is out from Biofil Chemicals & Pharmaceuticals Ltd. ( ($IN:BIOFILCHEM) ). Biofil Chemicals & Pharmaceuticals...

11M ago

Biofil Chemicals & Pharmaceuticals Ltd. Appoints New Company Secretary

Biofil Chemicals & Pharmaceuticals Ltd. ( ($IN:BIOFILCHEM) ) just unveiled an update. Biofil Chemicals & Pharmaceuticals Ltd. has...

11M ago

Biofil Chemicals Appoints New Company Secretary to Enhance Compliance

Biofil Chemicals & Pharmaceuticals Ltd. ( ($IN:BIOFILCHEM) ) has provided an update. Biofil Chemicals & Pharmaceuticals Ltd. has...

11M ago

BIOFILCHEM FAQ

What was Biofil Chemicals & Pharmaceuticals Ltd.’s price range in the past 12 months?

Biofil Chemicals & Pharmaceuticals Ltd. lowest stock price was ₹28.79 and its highest was ₹56.36 in the past 12 months.

What is Biofil Chemicals & Pharmaceuticals Ltd.’s market cap?

Biofil Chemicals & Pharmaceuticals Ltd.’s market cap is ₹494.72M.

When is Biofil Chemicals & Pharmaceuticals Ltd.’s upcoming earnings report date?

Biofil Chemicals & Pharmaceuticals Ltd.’s upcoming earnings report date is Jun 03, 2026 which is in 90 days.

How were Biofil Chemicals & Pharmaceuticals Ltd.’s earnings last quarter?

Biofil Chemicals & Pharmaceuticals Ltd. released its earnings results on Feb 13, 2026. The company reported ₹0.049 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.049.

Is Biofil Chemicals & Pharmaceuticals Ltd. overvalued?

According to Wall Street analysts Biofil Chemicals & Pharmaceuticals Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Biofil Chemicals & Pharmaceuticals Ltd. pay dividends?

Biofil Chemicals & Pharmaceuticals Ltd. does not currently pay dividends.

What is Biofil Chemicals & Pharmaceuticals Ltd.’s EPS estimate?

Biofil Chemicals & Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Biofil Chemicals & Pharmaceuticals Ltd. have?

Biofil Chemicals & Pharmaceuticals Ltd. has 16,273,800 shares outstanding.

What happened to Biofil Chemicals & Pharmaceuticals Ltd.’s price movement after its last earnings report?

Biofil Chemicals & Pharmaceuticals Ltd. reported an EPS of ₹0.049 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.921%.

Which hedge fund is a major shareholder of Biofil Chemicals & Pharmaceuticals Ltd.?

Currently, no hedge funds are holding shares in IN:BIOFILCHEM

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Biofil Chemicals & Pharmaceuticals Ltd.

Biofil Chemicals and Pharmaceuticals Limited engages in the pharmaceutical and chemical businesses primarily in India. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and plastic dippers and caps. It also provides job work service for manufacturing of pharmaceuticals. The company was incorporated in 1985 and is based in Indore, India.